Patents by Inventor JEFFERY T. L. SMITH

JEFFERY T. L. SMITH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-IL-6 antibodies for the treatment of anemia
    Patent number: 9304134
    Abstract: The present invention is directed to therapeutic methods using IL-6 antagonists such as anti-IL-6 antibodies and fragments thereof having binding specificity for IL-6 to prevent or treat anemia (e.g., anemia associated with chemotherapy) including persons on a treatment regimen with a drug or chemotherapy and/or radiation for cancer (e.g., head and neck cancer) that is associated with increased risk of anemia.
    Type: Grant
    Filed: November 23, 2011
    Date of Patent: April 5, 2016
    Assignee: ALDERBIO HOLDINGS LLC
    Inventor: Jeffery T. L. Smith
  • Anti-IL-6 antibodies for the treatment of anemia
    Patent number: 9274115
    Abstract: The present invention is directed to therapeutic methods using IL-6 antagonists such as anti-IL-6 antibodies and fragments thereof having binding specificity for IL-6 to prevent or treat anemia (e.g., anemia associated with chemotherapy) including persons on a treatment regimen with a drug or chemotherapy and/or radiation for cancer (e.g., head and neck cancer) that is associated with increased risk of anemia.
    Type: Grant
    Filed: November 23, 2011
    Date of Patent: March 1, 2016
    Assignee: ALDERBIO HOLDINGS LLC
    Inventor: Jeffery T. L. Smith
  • ANTI-IL-6 ANTIBODIES FOR THE TREATMENT OF ORAL MUCOSITIS
    Publication number: 20120189629
    Abstract: The present invention is directed to therapeutic methods using IL-6 antagonists such as anti-IL-6 antibodies and fragments thereof having binding specificity for IL-6 to prevent or treat mucositis (e.g., oral mucositis) including persons on a treatment regimen with a drug or chemotherapy and/or radiation for cancer (e.g., head and neck cancer) that is associated with increased risk of mucositis, including oral mucositis.
    Type: Application
    Filed: November 23, 2011
    Publication date: July 26, 2012
    Applicant: Alder Biopharmaceuticals, Inc.
    Inventor: Jeffery T. L. SMITH
  • ANTI-IL-6 ANTIBODIES FOR THE TREATMENT OF ANEMIA
    Publication number: 20120128626
    Abstract: The present invention is directed to therapeutic methods using IL-6 antagonists such as anti-IL-6 antibodies and fragments thereof having binding specificity for IL-6 to prevent or treat anemia (e.g., anemia associated with chemotherapy) including persons on a treatment regimen with a drug or chemotherapy and/or radiation for cancer (e.g., head and neck cancer) that is associated with increased risk of anemia.
    Type: Application
    Filed: November 23, 2011
    Publication date: May 24, 2012
    Applicant: ALDER BIOPHARMACEUTICALS, INC.
    Inventor: JEFFERY T. L. SMITH